{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T10:30:16Z","timestamp":1793961016526,"version":"4.8.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.eprac.2026.05.029","type":"journal-article","created":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T15:24:04Z","timestamp":1780586644000},"page":"1649-1656","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Diabetic Status, Advanced Age, and Hispanic Ethnicity Predict Poorer Weight Loss in Patients With Obesity Receiving Semaglutide"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2057-5202","authenticated-orcid":false,"given":"Nicole C.","family":"Cornet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam P.","family":"Buckholz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Yeung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonal","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick T.","family":"Magahis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reem Z.","family":"Sharaiha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tibor I.","family":"Krisko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett E.","family":"Fortune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn A.","family":"Newberry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"360","key":"10.1016\/j.eprac.2026.05.029_bib1","first-page":"1","article-title":"Prevalence of obesity and severe obesity among adults: United States, 2017-2018","author":"Hales","year":"2020","journal-title":"NCHS Data Brief"},{"issue":"10","key":"10.1016\/j.eprac.2026.05.029_bib2","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1038\/oby.2008.351","article-title":"Will all Americans become overweight or obese? estimating the progression and cost of the US obesity epidemic","volume":"16","author":"Wang","year":"2008","journal-title":"Obesity (Silver Spring)"},{"issue":"1","key":"10.1016\/j.eprac.2026.05.029_bib3","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/jama.2012.113905","article-title":"Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis","volume":"309","author":"Flegal","year":"2013","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.eprac.2026.05.029_bib4","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.gtc.2023.02.003","article-title":"Disparities in access and quality of obesity care","volume":"52","author":"Washington","year":"2023","journal-title":"Gastroenterol Clin North Am"},{"issue":"10","key":"10.1016\/j.eprac.2026.05.029_bib5","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1080\/14656566.2021.1888927","article-title":"An update on pharmacotherapeutic strategies for obesity","volume":"22","author":"Tchang","year":"2021","journal-title":"Expert Opin Pharmacother"},{"issue":"2","key":"10.1016\/j.eprac.2026.05.029_bib6","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s13679-018-0301-3","article-title":"Racial disparities in obesity treatment","volume":"7","author":"Byrd","year":"2018","journal-title":"Curr Obes Rep"},{"issue":"1","key":"10.1016\/j.eprac.2026.05.029_bib7","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/osp4.138","article-title":"Association of interleukin-6 polymorphisms with obesity or metabolic traits in young Mexican-Americans","volume":"4","author":"Boeta-Lopez","year":"2018","journal-title":"Obes Sci Pract"},{"issue":"2","key":"10.1016\/j.eprac.2026.05.029_bib8","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.healthplace.2008.09.004","article-title":"Obesity prevalence and the local food environment","volume":"15","author":"Morland","year":"2009","journal-title":"Health Place"},{"issue":"5","key":"10.1016\/j.eprac.2026.05.029_bib9","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.amepre.2014.07.005","article-title":"Distance to store, food prices, and obesity in urban food deserts","volume":"47","author":"Ghosh-Dastidar","year":"2014","journal-title":"Am J Prev Med"},{"issue":"3","key":"10.1016\/j.eprac.2026.05.029_bib10","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/s13679-020-00398-7","article-title":"Socioeconomics of obesity","volume":"9","author":"Anekwe","year":"2020","journal-title":"Curr Obes Rep"},{"issue":"3","key":"10.1016\/j.eprac.2026.05.029_bib11","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/s41366-021-01024-9","article-title":"A national evaluation of geographic accessibility and provider availability of obesity medicine diplomates in the United States between 2011 and 2019","volume":"46","author":"Pollack","year":"2022","journal-title":"Int J Obes (Lond)"},{"issue":"5 Suppl","key":"10.1016\/j.eprac.2026.05.029_bib12","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1016\/j.jada.2010.03.009","article-title":"Limited English proficiency is a barrier to receipt of advice about physical activity and diet among Hispanics with chronic diseases in the United States","volume":"110","author":"Lopez-Quintero","year":"2010","journal-title":"J Am Diet Assoc"},{"issue":"3","key":"10.1016\/j.eprac.2026.05.029_bib13","first-page":"308","article-title":"Racial disparities in the risk of developing obesity-related diseases: a cross-sectional study","volume":"22","author":"Zhang","year":"2012","journal-title":"Ethn Dis"},{"issue":"7","key":"10.1016\/j.eprac.2026.05.029_bib14","doi-asserted-by":"crossref","first-page":"665","DOI":"10.3109\/00365529609009147","article-title":"Secretion of the incretin hormones glucagon-like peptide-1 and gastric inhibitory polypeptide correlates with insulin secretion in normal man throughout the day","volume":"31","author":"Orskov","year":"1996","journal-title":"Scand J Gastroenterol"},{"issue":"4","key":"10.1016\/j.eprac.2026.05.029_bib15","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/BF01316798","article-title":"Truncated GLP-1 (proglucagon 78-107-amide) inhibits gastric and pancreatic functions in man","volume":"38","author":"Wettergren","year":"1993","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.eprac.2026.05.029_bib16","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.2147\/DDDT.S58459","article-title":"Liraglutide and obesity: a review of the data so far","volume":"9","author":"Ladenheim","year":"2015","journal-title":"Drug Des Devel Ther"},{"issue":"11","key":"10.1016\/j.eprac.2026.05.029_bib17","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa2032183","article-title":"Once-weekly semaglutide in adults with overweight or obesity","volume":"384","author":"Wilding","year":"2021","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.eprac.2026.05.029_bib18","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1002\/oby.21358","article-title":"Is 5% weight loss a satisfactory criterion to define clinically significant weight loss?","volume":"23","author":"Williamson","year":"2015","journal-title":"Obesity (Silver Spring)"},{"issue":"25 Suppl 2","key":"10.1016\/j.eprac.2026.05.029_bib19","first-page":"S102","article-title":"2013 AHA\/ACC\/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and The Obesity Society","volume":"129","author":"Jensen","year":"2014","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.eprac.2026.05.029_bib20","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1097\/MCG.0b013e3181b57475","article-title":"Effect of weight loss on nonalcoholic fatty liver disease","volume":"43","author":"Patel","year":"2009","journal-title":"J Clin Gastroenterol"},{"issue":"3","key":"10.1016\/j.eprac.2026.05.029_bib21","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1378\/chest.09-0360","article-title":"Interactions between obesity and obstructive sleep apnea: implications for treatment","volume":"137","author":"Romero-Corral","year":"2010","journal-title":"Chest"},{"issue":"14","key":"10.1016\/j.eprac.2026.05.029_bib22","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1001\/jama.2021.1831","article-title":"Effect of subcutaneous semaglutide vs placebo as an adjunct to intensive behavioral therapy on body weight in adults with overweight or obesity","volume":"325","author":"Romero-Corral","year":"2021","journal-title":"JAMA"},{"issue":"14","key":"10.1016\/j.eprac.2026.05.029_bib24","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1001\/jama.2021.3224","article-title":"Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity","volume":"325","author":"Rubino","year":"2021","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.eprac.2026.05.029_bib25","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1038\/s41591-022-02026-4","article-title":"Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial","volume":"28","author":"Garvey","year":"2022","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.eprac.2026.05.029_bib26","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1001\/jama.2021.23619","article-title":"Effect of weekly subcutaneous semaglutide vs daily liraglutide on body weight in adults with overweight or obesity without diabetes: the STEP 8 randomized clinical trial","volume":"327","author":"Rubino","year":"2022","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.eprac.2026.05.029_bib27","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1111\/dom.12932","article-title":"Effects of once-weekly semaglutide on appetite, energy intake, control of eating, food preference and body weight in subjects with obesity","volume":"19","author":"Blundell","year":"2017","journal-title":"Diabetes Obes Metab"},{"issue":"11","key":"10.1016\/j.eprac.2026.05.029_bib28","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.4158\/EP151181.OR","article-title":"Effects of liraglutide 3.0 mg on weight and risk factors in Hispanic versus non-Hispanic populations: subgroup analysis from scale randomized trials","volume":"22","author":"O'Neil","year":"2016","journal-title":"Endocr Pract"},{"issue":"7","key":"10.1016\/j.eprac.2026.05.029_bib29","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1111\/dom.12653","article-title":"Efficacy and safety of liraglutide, a once-daily human glucagon-like peptide-1 analogue, in Latino\/Hispanic patients with type 2 diabetes: post hoc analysis of data from four phase III trials","volume":"18","author":"Davidson","year":"2016","journal-title":"Diabetes Obes Metab"},{"issue":"2","key":"10.1016\/j.eprac.2026.05.029_bib30","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgz072","article-title":"Efficacy and safety of semaglutide for type 2 diabetes by race and ethnicity: a post hoc analysis of the SUSTAIN trials","volume":"105","author":"DeSouza","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.eprac.2026.05.029_bib31","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.cgh.2017.09.041","article-title":"Racial and ethnic disparities in nonalcoholic fatty liver disease prevalence, severity, and outcomes in the United States: a systematic review and meta-analysis","volume":"16","author":"Rich","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.eprac.2026.05.029_bib32","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.3945\/ajcn.113.082685","article-title":"Food-group and nutrient-density intakes by Hispanic and Latino backgrounds in the Hispanic Community Health Study\/Study of Latinos","volume":"99","author":"Siega-Riz","year":"2014","journal-title":"Am J Clin Nutr"},{"issue":"3","key":"10.1016\/j.eprac.2026.05.029_bib33","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1353\/hpu.2016.0112","article-title":"Sociodemographic factors, acculturation, and nutrition management among Hispanic American adults with self-reported diabetes","volume":"27","author":"Yoshida","year":"2016","journal-title":"J Health Care Poor Underserved"},{"issue":"3","key":"10.1016\/j.eprac.2026.05.029_bib34","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.bodyim.2012.04.003","article-title":"Considering J.Lo and Ugly Betty: a qualitative examination of risk factors and prevention targets for body dissatisfaction, eating disorders, and obesity in young Latina women","volume":"9","author":"Franko","year":"2012","journal-title":"Body Image"},{"issue":"2","key":"10.1016\/j.eprac.2026.05.029_bib35","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/oby.23638","article-title":"Obesity among Latinx people in the United States: a review","volume":"31","author":"Alem\u00e1n","year":"2023","journal-title":"Obesity"},{"issue":"11","key":"10.1016\/j.eprac.2026.05.029_bib36","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.3390\/jcm13113206","article-title":"Food insecurity in Hispanic populations is associated with an increased risk of hepatic steatosis: a nationally representative study","volume":"13","author":"Niezen","year":"2024","journal-title":"J Clin Med"},{"issue":"2","key":"10.1016\/j.eprac.2026.05.029_bib37","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/SLA.0000000000004493","article-title":"Disparity between United States adolescent class II and III obesity trends and bariatric surgery utilization, 2015-2018","volume":"276","author":"Messiah","year":"2022","journal-title":"Ann Surg"},{"issue":"3","key":"10.1016\/j.eprac.2026.05.029_bib38","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1007\/s11695-020-04987-2","article-title":"Pharmacotherapy for obesity-trends using a population level national database","volume":"31","author":"Elangovan","year":"2021","journal-title":"Obes Surg"},{"issue":"6","key":"10.1016\/j.eprac.2026.05.029_bib39","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1007\/s12325-022-02153-x","article-title":"Efficacy of GLP-1 RA approved for weight management in patients with or without diabetes: a narrative review","volume":"39","author":"Jensterle","year":"2022","journal-title":"Adv Ther"},{"issue":"4","key":"10.1016\/j.eprac.2026.05.029_bib40","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1017\/S002966511500169X","article-title":"Muscle loss and obesity: the health implications of sarcopenia and sarcopenic obesity","volume":"74","author":"Wannamethee","year":"2015","journal-title":"Proc Nutr Soc"},{"issue":"1","key":"10.1016\/j.eprac.2026.05.029_bib41","doi-asserted-by":"crossref","first-page":"49","DOI":"10.4235\/agmr.22.0012","article-title":"What is the optimal body mass index range for older adults?","volume":"26","author":"K\u0131ska\u00e7","year":"2022","journal-title":"Ann Geriatr Med Res"},{"issue":"3","key":"10.1016\/j.eprac.2026.05.029_bib42","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.soard.2012.12.009","article-title":"Effect of preoperative body mass index on weight loss after obesity surgery","volume":"9","author":"Ochner","year":"2013","journal-title":"Surg Obes Relat Dis"},{"issue":"3","key":"10.1016\/j.eprac.2026.05.029_bib43","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/dom.12824","article-title":"Occurrence of nausea, vomiting and diarrhoea reported as adverse events in clinical trials studying glucagon-like peptide-1 receptor agonists: a systematic analysis of published clinical trials","volume":"19","author":"Bettge","year":"2017","journal-title":"Diabetes Obes Metab"},{"issue":"5","key":"10.1016\/j.eprac.2026.05.029_bib44","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/dom.12872","article-title":"Upper and\/or lower gastrointestinal adverse events with glucagon-like peptide-1 receptor agonists: incidence and consequences","volume":"19","author":"Horowitz","year":"2017","journal-title":"Diabetes Obes Metab"},{"issue":"6","key":"10.1016\/j.eprac.2026.05.029_bib45","doi-asserted-by":"crossref","first-page":"R211","DOI":"10.1530\/EJE-19-0566","article-title":"Management of endocrine disease: are all GLP-1 agonists equal in the treatment of type 2 diabetes?","volume":"181","author":"Nauck","year":"2019","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"10.1016\/j.eprac.2026.05.029_bib46","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/dom.14551","article-title":"Gastrointestinal tolerability of once-weekly semaglutide 2.4 mg in adults with overweight or obesity, and the relationship between gastrointestinal adverse events and weight loss","volume":"24","author":"Wharton","year":"2022","journal-title":"Diabetes Obes Metab"},{"issue":"3","key":"10.1016\/j.eprac.2026.05.029_bib47","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/dom.13120","article-title":"Semaglutide improves postprandial glucose and lipid metabolism, and delays first-hour gastric emptying in subjects with obesity","volume":"20","author":"Hjerpsted","year":"2018","journal-title":"Diabetes Obes Metab"},{"issue":"3","key":"10.1016\/j.eprac.2026.05.029_bib48","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/dom.14280","article-title":"The effect of semaglutide 2.4 mg once weekly on energy intake, appetite, control of eating, and gastric emptying in adults with obesity","volume":"23","author":"Friedrichsen","year":"2021","journal-title":"Diabetes Obes Metab"},{"issue":"6","key":"10.1016\/j.eprac.2026.05.029_bib49","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.133429","article-title":"Semaglutide lowers body weight in rodents via distributed neural pathways","volume":"5","author":"Gabery","year":"2020","journal-title":"JCI Insight"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X26010219?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X26010219?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T10:09:18Z","timestamp":1793959758000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X26010219"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":48,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S1530891X26010219"],"URL":"https:\/\/doi.org\/10.1016\/j.eprac.2026.05.029","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diabetic Status, Advanced Age, and Hispanic Ethnicity Predict Poorer Weight Loss in Patients With Obesity Receiving Semaglutide","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eprac.2026.05.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 AACE. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}